CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2, Open-label, Study to Evaluate the Safety and Immunogenicity of a Heterologous 2-dose Vaccination Regimen Using Ad26.ZEBOV, MVA-BN-Filo in Adults and Children Originally Enrolled in the Control Arm of the EBOVAC-Salone Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05284097
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:49.147405+00:00
Published At: 2025-05-11T00:00:00+00:00
Record Updated At: 2025-05-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Virus Diseases", "Hemorrhagic Fever, Ebola", "Infections", "Hemorrhagic Fevers, Viral", "RNA Virus Infections", "Filoviridae Infections", "Mononegavirales Infections", "Vaccines", "Immunologic Factors", "Physiological Effects of Drugs", "Ebola"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-05-11"
protocolSection.identificationModule.nctId: "NCT05284097"
protocolSection.identificationModule.officialTitle: "A Phase 2, Open-label, Study to Evaluate the Safety and Immunogenicity of a Heterologous 2-dose Vaccination Regimen Using Ad26.ZEBOV, MVA-BN-Filo in Adults and Children Originally Enrolled in the Control Arm of the EBOVAC-Salone Study"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.